Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Clinical study on the efficacy and safety of Jetongdan on the patients with osteoarthritis of the knee

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2005, v.26 no.2, pp.231-240










  • Downloaded
  • Viewed

Abstract

Objectives: In order to investigate the efficacy and safety of Jetongdan, the newly developed herbal medicine, placebo-controlled, randomized clinical trial on the patients with osteoarthritis of the knee was fulfilled. Methods: Data were obtained from 80 patients with OA of the knee. After enrollment, they were asked to answer the disease-specific questionnaire (Western Ontario and McMaster Universities (WOMAC) OA index) and analysed with the erythrocyte sedimentation rate (ESR) in order to evaluate the efficacy of Jetongdan, and analysed with aspartate transaminase (AST) level, alanine transaminase (ALT) level, blood urea nitrogen (BUN) level, creatinine (Cr) level in order to evaluate the safety of Jetongdan. Results: The liver function and renal function was not deteriorated after medication of Jetongdan. Composite WOMAC score, physical function subscale was improved, but pain subscale, stiffness subscale, and ESR was not improved by Jetongdan. It was considered because the baseline characteristics of the two group was not homogenized after randomization. Conclusions: In conclusion, Jetongdan could be a promising treatment option on osteoarthritis of the knee. Further study in the large population with appropriate severity grade were recommended.

keywords
Jetongdan, Osteoarthritis of knee, WOMAC, ESR, efficacy, safety


Reference

1

(1999) Level of physical activity and the risk of radiographic and symptomatic knee osteoarthritis in the elderly,

2

(1987) The prevalence of knee osteoarthritis in the elderly:the Framingham study,

3

(1992) Longitudinal radiologic evaluation of osteoarthritis of the knee,

4

(2004) The impact of osteoarthritis,

5

(2003jun) Integrative approaches to pain management:how to get the best of both worlds,

6

(2000) The role of complementary and alternative medicine,

7

(1998nov) Alternative medicine meets science,

8

(2004) Monitoring osteoarthritis progression and therapy,

9

(1997) Recommendations for a core set of outcome measures for future phase III clinical trials in knee Consensus development at OMERACT III,

10

(19881833-1840) Validation study of WOMAC a health status instrument for measuring clincally important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee,

11

(1986) Development of criteria for the classification and reporting of osteoarthritis Classification of osteoarthritis of the knee Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association,

12

(2005) Pathogenesis and management of pain in osteoarthritis,

13

(2004) Risk factors for osteoarthritis,

14

(2003) Osteoarthritis of knee-clinical assessments and inflammatory markers,

15

(2004) 퇴행성관절염 한방치료에 대한 최근 연구동향-임상연구 방법론을 중심으로-,

16

Outcome variables for osteoarthritis clinical trials The OMERACT-OARSI set of responder criteria,

17

(2003) Assessment of disease activity,

18

(1980) Measurement of patient outcome in arthritis,

19

(1997) health related quality-of-life in patients with rheumatoid arthritis,

20

(1998) Comparison of the WOMAC osteoarthritis index and a self-report format of the self-administered Lequesne-Algofunctional index in patients with knee and hip osteoarthritis, Western Ontario and McMaster Universities

21

(2003) Linking osteoarthritis-specific health-status measures to the International Classification of Functioning,

22

(1995) Outcome measurement in osteoarthritis clinical trials,

23

(1997) Statistics notes:Cronbach's alpha,

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine